Recombinant Human MYLK Protein，His

MYLK, or Myosin Light Chain Kinase, is a critical enzyme involved in various cellular processes, particularly in muscle contraction and regulation of the cytoskeleton. The interest in MYLK has surged due to its pivotal role in smooth muscle function and cardiac physiology. Dysregulation of MYLK activity has been implicated in various pathological conditions, including hypertension, asthma, and cardiac dysfunction, making it a potential therapeutic target. Recent research has focused on the molecular mechanisms governing MYLK's activity, including its regulation by calcium and calmodulin, as well as its involvement in signaling pathways that affect cell migration and proliferation. Reconstituting MYLK in experimental models can elucidate its functional dynamics and provide insights into how its activity can be modulated in disease states. Advances in recombinant protein technology have enabled scientists to produce and study MYLK in vitro, allowing for a better understanding of its structure-function relationship and interactions with other proteins. This research aims to pave the way for developing novel interventions that target MYLK-related pathways, potentially leading to innovative treatments for diseases linked to smooth muscle and cardiac dysfunction. Overall, the investigation of MYLK as a recombinant protein holds significant promise in both basic biology and clinical application, addressing vital questions regarding its role in health and disease.